Divi's Laboratories Ltd. Share Price
6,473.50 +4.50 (+0.07%)Founded in 1990, Divi’s Laboratories Limited is a prominent leader in the pharmaceutical industry. They hold a dominant position in the export market. It is based in Hyderabad, India.
Business Segment
The business operations include:
- Primary Business Segment: manufacturing and sale of Active Pharmaceutical Ingredients, intermediates, custom pharmaceutical services, and nutraceutical ingredients
- Product Portfolio: includes Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam and more
In addition to generic business, the company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management.
Geographical Presence
The geographical reach spans Asia, America, Europe, and the rest of the world. The company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.
Fundamentals
Market Cap
₹1,69,953CrEPS
₹82.53Book Value/Share
₹563.87P/E Ratio (TTM)
69.10Industry P/E (TTM)
41.20P/B Ratio
11.47Long Term D/E
0.00ROE
15.35%Dividend Yield (TTM)
0.50%Factor Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Outperformer
Very Expensive
Good Quality
Low Price Fluctuation
Analysts are Bullish
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Factor Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Divi's Laboratories Ltd.
Divi's Laboratories Ltd. share price is ₹6,473.50 as of 05/12/2025, 5:34:55 pm. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
Divi's Laboratories Ltd. reported an ROE of 15.35 for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Divi's Laboratories Ltd., Promoter held 51.90%, the FII held 19.40%, DII held 19.80%, and the public held 9.00% of the total shares.
You can easily buy shares of Divi's Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
The fair value of Divi's Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages5
Bearish Moving Averages11
5 Day
6,448.2010 Day
6,438.6020 Day
6,490.3030 Day
6,543.0050 Day
6,392.70100 Day
6,340.80150 Day
6,409.40200 Day
6,243.90Indicators
RSI (14)
49.74MACD (12, 26)
-9.10MACD Signal Line (9)
2.63MFI (14)
34.49ATR (14)
115.53ADX (14)
15.52ROC (21)
-4.93ROC (125)
-2.41Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
